We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
Cap. Flow
+$1.82B
Cap. Flow %
2.24%
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$164M
2
MSFT icon
Microsoft
MSFT
+$157M
3
AMZN icon
Amazon
AMZN
+$75.7M
4
TSLA icon
Tesla
TSLA
+$50M
5
GEHC icon
GE HealthCare
GEHC
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 25.37%
2 Healthcare 13.58%
3 Financials 12.66%
4 Consumer Discretionary 10.75%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSI icon
2701
Rush Street Interactive
RSI
$2.88B
$234K ﹤0.01%
75,133
+959
+1% +$3.68K
INNV icon
2702
InnovAge Holding
INNV
$1.52B
$231K ﹤0.01%
28,991
+306
+1% +$2.22K
HFFG icon
2703
HF Foods Group
HFFG
$83.4M
$230K ﹤0.01%
58,568
+3,298
+6% +$13.8K
PEPG icon
2704
PepGen
PEPG
$197M
$230K ﹤0.01%
18,810
+1,979
+12% +$31K
THRX
2705
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$229K ﹤0.01%
25,822
+820
+3% +$8.05K
DC icon
2706
Dakota Gold
DC
$804M
$228K ﹤0.01%
62,996
+623
+1% +$2.06K
LBC
2707
DELISTED
Luther Burbank Corporation Common Stock
LBC
$228K ﹤0.01%
24,029
+796
+3% +$8.82K
ARIS
2708
DELISTED
Aris Water Solutions
ARIS
$227K ﹤0.01%
29,081
+1,282
+5% +$16.5K
NGM
2709
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$227K ﹤0.01%
55,692
+985
+2% +$4.55K
AMRX icon
2710
Amneal Pharmaceuticals
AMRX
$5.79B
$225K ﹤0.01%
162,185
+1,672
+1% +$3.33K
BWFG icon
2711
Bankwell Financial Group
BWFG
$533M
$223K ﹤0.01%
8,989
HPK icon
2712
HighPeak Energy
HPK
$910M
$222K ﹤0.01%
9,641
+807
+9% +$20.5K
NC icon
2713
NACCO Industries
NC
$320M
$222K ﹤0.01%
6,144
+73
+1% +$2.74K
CRD.A icon
2714
Crawford & Co Class A
CRD.A
$669M
$221K ﹤0.01%
26,426
-195
-0.7% -$1.27K
SKWD icon
2715
Skyward Specialty Insurance
SKWD
$2.58B
$220K ﹤0.01%
+10,073
New +$196K
TDUP icon
2716
ThredUp
TDUP
$422M
$220K ﹤0.01%
86,958
+542
+0.6% +$1.01K
RDVT icon
2717
Red Violet
RDVT
$924M
$218K ﹤0.01%
12,396
+362
+3% +$7.76K
CPSS icon
2718
Consumer Portfolio Services
CPSS
$206M
$217K ﹤0.01%
20,254
-6
-0% -$61
DHX icon
2719
DHI Group
DHX
$173M
$217K ﹤0.01%
55,951
+1,244
+2% +$5.9K
GWRS icon
2720
Global Water Resources
GWRS
$219M
$216K ﹤0.01%
17,385
+340
+2% +$4.59K
MPAA icon
2721
Motorcar Parts of America
MPAA
$258M
$216K ﹤0.01%
29,085
-29,778
-51% -$355K
FULC icon
2722
Fulcrum Therapeutics
FULC
$297M
$215K ﹤0.01%
75,507
+15,777
+26% +$141K
TBCH
2723
Turtle Beach Corp
TBCH
$277M
$215K ﹤0.01%
21,476
+89
+0.4% +$755
APLD icon
2724
Applied Digital
APLD
$8.41B
$214K ﹤0.01%
95,436
+35,176
+58% +$87.8K
COOK icon
2725
Traeger
COOK
$172M
$214K ﹤0.01%
1,043
+63
+6% +$11.3K

Similar funds

RhumbLine Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
  • RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
  • RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
  • RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
  • RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
  • RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.